Trials / Conditions / Nicotine Addiction

Nicotine Addiction

56 registered clinical trials studyying Nicotine Addiction — 11 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Non-Invasive Deep Brain Neuromodulation for Smoking Cessation NCT07298902	The University of Texas Health Science Center, Houston	N/A
Recruiting	Effect of Product Characteristics on the Abuse Liability of Nicotine Pouches NCT07165808	Emory University	N/A
Not Yet Recruiting	Semaglutide for Smoking Cessation in Patients With Diabetes NCT07059377	Ottawa Heart Institute Research Corporation	Phase 3
Recruiting	CONNECT Cancer Survivors With Tobacco Treatment NCT07020273	Washington University School of Medicine	N/A
Recruiting	Metabolome and Gut Microbiome Changes During Smoking Cessation in Long-term Drug Therapy in a Therapeutic Comm NCT06803706	Sigmund Freud PrivatUniversitat	N/A
Recruiting	Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder NCT06582888	University of California, San Diego	EARLY_Phase 1
Enrolling By Invitation	Developing Evidence to Inform Regulatory Policy on Nicotine Content in E-Liquids NCT06619964	Rochester Institute of Technology	—
Completed	Examining the Efficacy of a Newly Developed Smoking Cessation Program NCT06746025	Quit Center LLC	—
Completed	Sex Differences in E-cig Perception: Study 1 NCT05432830	Yale University	N/A
Recruiting	Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects NCT06254001	National Institute of Respiratory Diseases, Mexico	Phase 4
Completed	A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults NCT05897242	Fred Hutchinson Cancer Center	N/A
Recruiting	Unraveling the Genetic Basis of Nicotine Addiction for Novel Therapeutic Strategies NCT06471387	University of Cyprus	—
Unknown	Effects of Exercises on Functional Capacity NCT06291584	Kırklareli University	N/A
Completed	Effectiveness of N-Acetylcysteine (NAC) in Motivational Enhancement Therapy for Nicotine Addiction NCT05903014	Indonesia University	Phase 4
Completed	Effects of Semaglutide on Nicotine Intake NCT05530577	University of North Carolina, Chapel Hill	Phase 2
Completed	Acute Pharmacokinetic and Pharmacodynamic Effects of "Tobacco-Free" Oral Nicotine Pouches in Smokers NCT05335915	Johns Hopkins University	Phase 1
Completed	Assess the Influence of Nicotine Flux and Nicotine Form on Subjective Effects Related to Dependency NCT05430334	American University of Beirut Medical Center	N/A
Unknown	Mobile Health for Problematic Behaviors and Substance Use NCT05434429	PredictWatch	N/A
Recruiting	Circuitry-Guided Smoking Cessation in Schizophrenia (UH3) NCT05276050	The University of Texas Health Science Center, Houston	N/A
Active Not Recruiting	Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy NCT06910566	Centre Oscar Lambret	—
Completed	Comparative Effectiveness of Cystine Versus Nicotine Replacement Therapy NCT04126135	Loma Linda University	Phase 4
Recruiting	Biopsychosocial Predictors of Nicotine Relapse NCT06470321	University of Cyprus	N/A
Completed	Compensatory Behavior of E-cig Users in Response to Reduced Nicotine E-liquids NCT06602492	Rochester Institute of Technology	EARLY_Phase 1
Completed	Quit Smoking Study for People Who Use E-Cigarettes NCT04946825	University of Vermont	Phase 2
Completed	Electronic Cigarettes as a Harm Reduction Strategy Among People Living With HIV/AIDS NCT04218708	NYU Langone Health	N/A
Completed	Acute Effects of Vaping Nicotine on Cognition in Young Adults NCT04901208	Yale University	N/A
Completed	Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use NCT02870218	Rose Research Center, LLC	Phase 2
Withdrawn	Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification NCT05440721	Click Therapeutics, Inc.	N/A
Completed	Innovative Digital Therapeutic for Smoking Cessation NCT03694327	My Digital Study	N/A
Completed	Circuitry-Guided Smoking Cessation in Schizophrenia NCT03281629	University of Maryland, Baltimore	N/A
Completed	Feasibility Trial of a Tailored Smoking Cessation App for People With Serious Mental Illness NCT03069482	Duke University	Phase 1
Completed	Nicotine's Effect on Cancer Stem Cell Markers in Human Umbilical Cord Tissue NCT06678152	Celal Bayar University	—
Completed	Nicotine Reinforcement and Aversion in Young Adult Light Smokers NCT01495819	Yale University	EARLY_Phase 1
Completed	Clinical Trial of Smoking Cessation Mobile Phone Program NCT02656745	Click Therapeutics, Inc.	N/A
Completed	Neural Mechanisms Associated With Risk of Smoking Relapse NCT02837510	University of Pennsylvania	N/A
Withdrawn	Nicotine Virtual Reality Conditioned Place Preference NCT06259630	University of Chicago	Phase 4
Completed	tDCS Effects on Resisting Smoking: Dose Ranging Study NCT02624284	University of Pennsylvania	N/A
Completed	Effects of Brief Training on Craving Regulation NCT02153749	Yale University	N/A
Unknown	Control Systems Approach to Predicting Individualized Dynamics of Nicotine Cravings NCT02643914	Stony Brook University	N/A
Completed	The END Perioperative Smoking Pilot Study NCT02482233	University of California, San Francisco	Phase 4
Completed	Acute and Chronic Nicotine Modulation of Reinforcement Learning NCT01830842	Duke University	N/A
Completed	Extinction Updating in Reconsolidation NCT02154685	Medical University of South Carolina	N/A
Completed	Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine NCT01944423	University of Texas at Austin	EARLY_Phase 1
Terminated	e-Cigarettes Versus NRT Gum for Smoking Cessation NCT01925781	Creighton University	Phase 4
Terminated	Effects of ABT-089 on Smoking Abstinence Symptoms and Reward NCT01756053	University of Pennsylvania	Phase 2
Completed	Nicotine Receptor Levels and Smoking Cessation NCT01788943	University of Pennsylvania	—
Terminated	A Smoking Intervention Study Using Scheduled Gradual Reduction With Varenicline to Help With Cessation NCT01772641	Icahn School of Medicine at Mount Sinai	Phase 4
Completed	Computer-Facilitated 5A's for Smoking Cessation in Primary Care NCT02046408	University of California, San Francisco	N/A
Completed	Effects of rTMS on Cigarette Smoking and Cognition in Schizophrenia NCT01523730	Centre for Addiction and Mental Health	N/A
Completed	Effect of Galantamine on Smoking Abstinence NCT01548638	University of Pennsylvania	Phase 2
Completed	Cognitive Training for Nicotine Dependence NCT01252966	University of Pennsylvania	N/A
Completed	Pharmacogenetics of Nicotine Addiction Treatment NCT01314001	University of Pennsylvania	Phase 3
Completed	Nicotinic Receptor Levels After Stopping Smoking NCT01704573	University of Pennsylvania	—
Completed	STOP Study: Effectiveness of Zyban in a Clinical Population NCT01015170	Centre for Addiction and Mental Health	Phase 4
Completed	Investigation of Cycloserine as a Smoking Cessation Treatment NCT01062932	Baylor College of Medicine	Phase 1
Completed	Quantitation of Human Cerebral Nicotinie Receptors With 2[18F]FA-85380 and PET Healthy Non-smokers and Ex-Smok NCT01038245	National Institute on Drug Abuse (NIDA)	—